SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-017156
Filing Date
2016-04-29
Accepted
2016-04-29 16:01:24
Documents
4
Period of Report
2016-06-22
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A cdtx-def14a_20160622.htm DEF 14A 772566
2 GRAPHIC globsjzkurmn000001.jpg GRAPHIC 3401
3 GRAPHIC globsjzkurmn000003.jpg GRAPHIC 96724
4 GRAPHIC globsjzkurmn000002.jpg GRAPHIC 87635
  Complete submission text file 0001564590-16-017156.txt   1032812
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36912 | Film No.: 161606404
SIC: 2836 Biological Products, (No Diagnostic Substances)